Crown Advisors Management, Inc. Tandem Diabetes Care Inc Transaction History

Crown Advisors Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$101.89 - $150.09 $2.55 Million - $3.75 Million	-25,000 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$81.28 - $104.34 $1.22 Million - $1.57 Million	-15,000 Reduced 37.5%	25,000 $2.21 Million
Q3 2020 Nov 05, 2020	SELL	$95.43 - $116.09 $954,300 - $1.16 Million	-10,000 Reduced 20.0%	40,000 $4.54 Million
Q4 2019 Feb 05, 2020	SELL	$53.13 - $71.19 $1.33 Million - $1.78 Million	-25,000 Reduced 33.33%	50,000 $2.98 Million
Q3 2019 Nov 12, 2019	SELL	$57.11 - $73.3 $1.43 Million - $1.83 Million	-25,000 Reduced 25.0%	75,000 $4.42 Million
Q1 2019 May 08, 2019	BUY	$32.25 - $73.56 $806,250 - $1.84 Million	25,000 Added 33.33%	100,000 $6.35 Million
Q4 2018 Feb 07, 2019	BUY	$28.45 - $40.65 $2.13 Million - $3.05 Million	75,000 New	75,000 $2.85 Million

362

73.7M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.32B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Crown Advisors Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Crown Advisors Management, Inc. with notifications on news.